Estudos Randomizados
Estudo randomizado fase 2 | Uso profilático de garadacimabe em pacientes com angioedema hereditário.
21 Mar, 2022 | 16:08hProphylactic use of an anti-activated factor XII monoclonal antibody, garadacimab, for patients with C1-esterase inhibitor-deficient hereditary angioedema: a randomised, double-blind, placebo-controlled, phase 2 trial – The Lancet (link para o resumo – $ para o texto completo)
Comentário: Garadacimab significantly reduces frequency of hereditary angioedema exacerbations – Physician’s Weekly
Estudo randomizado | Contezolida oral vs. linezolida em adultos com infecções cutâneas e de partes moles complicadas.
21 Mar, 2022 | 15:58hA Phase III multicentre, randomized, double-blind trial to evaluate the efficacy and safety of oral contezolid versus linezolid in adults with complicated skin and soft tissue infections – Journal of Antimicrobial Therapy (link para o resumo – $ para o texto completo)
Comentário no Twitter
Phase III efficacy & safety of oral contezolid Vs linezolid in adults with c.SSTIs
📌Non inferior
📌Interestingly:Contezolid demonstrated significant lower incidence thrombocytopenia (0% Wow vs 2.3%) & leucopenia (0.3% vs 3.4%) than linezolid
📌QIDP https://t.co/wSvxUInnkZ— Antibiotic Steward Bassam Ghanem (@ABsteward) March 11, 2022
Estudo randomizado | Radioterapia de curto prazo com quimioterapia vs. quimiorradioterapia de longo prazo no câncer retal localmente avançado.
21 Mar, 2022 | 15:53hEstudo randomizado | Em mulheres submetidas a cirurgia citorredutora para câncer de ovário, a adição de quimioterapia intraperitoneal hipertérmica não melhorou a progressão livre de doença e a sobrevida geral.
16 Mar, 2022 | 17:35hConteúdos relacionados:
M-A: Secondary cytoreductive surgery in platinum-sensitive recurrent ovarian cancer.
RCT: Cytoreductive surgery for relapsed ovarian cancer.
Estudo randomizado aberto | Azitromicina para asma mal controlada em crianças.
15 Mar, 2022 | 13:09hAzithromycin for Poorly Controlled Asthma in Children: A randomized controlled trial – CHEST (link para o resumo – $ para o texto completo)
Comentário: Adding azithromycin to standard care improves asthma control, exacerbations in children – Healio
Conteúdo relacionado: Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma
Estudo randomizado | Vortioxetina 5, 10 e 20 mg reduz significativamente o risco de recaída em comparação ao placebo em pacientes com transtorno depressivo maior remitente.
14 Mar, 2022 | 13:42h
Comentário no Twitter
RCT: In patients with remitted MDD with 10 mg/day of vortioxetine, time to relapse was longer and cumulative relapse rates were lower for vortioxetine 5 mg (19.3%), 10 mg (17.9%), and 20 mg (17.4%) versus placebo (32.5%) over 28 weeks (p<0.05 for all) https://t.co/LzwFaxVt4d pic.twitter.com/Gq3lLTtVcS
— PfOL (@psychopharmacol) March 11, 2022
Estudo randomizado | Metenamina hipurato (um tratamento preventivo não antibiótico) é não inferior a antibióticos profiláticos para tratar infecções recorrentes de trato urinário em mulheres.
11 Mar, 2022 | 15:19hComunicado de imprensa: Antiseptic drug as good as antibiotics for preventing recurrent urinary tract infections – BMJ Newsroom
Editorial: Methenamine hippurate for recurrent urinary tract infections – The BMJ
Comentários:
Trial supports antibiotic alternative for recurrent urinary infections – CIDRAP
Nonantibiotic Prophylaxis Noninferior for Recurrent UTI – HealthDay
Comentário no Twitter
The antiseptic drug methenamine hippurate is as good as antibiotics for preventing recurrent urinary tract infections in women, finds this trial
Includes a visual abstract displaying the findings #BMJInfographic https://t.co/LJNx2OEKhO @chrisharding123 pic.twitter.com/CjxWtjao6r
— The BMJ (@bmj_latest) March 10, 2022
Estudo randomizado | Sobrevida geral do câncer de mama avançado com ribociclibe e letrozol.
11 Mar, 2022 | 14:56hOverall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer – New England Journal of Medicine (link para o resumo – $ para o texto completo)
Comentários:
Adding Ribociclib to Letrozole Prolongs Survival in Advanced Breast Cancer – HealthDay
Estudo randomizado | Em UTI pediátricas, uma intervenção unificada que enfatize o treinamento em ressuscitação cardiopulmonar fisiologicamente focado não melhorou os desfechos de parada cardíaca.
11 Mar, 2022 | 14:48hEffect of Physiologic Point-of-Care Cardiopulmonary Resuscitation Training on Survival With Favorable Neurologic Outcome in Cardiac Arrest in Pediatric ICUs: A Randomized Clinical Trial – JAMA (link para o resumo – $ para o texto completo)
Comentário: CPR Intervention Failed to Improve Survival in Kids With Cardiac Arrest — Physiologically focused CPR training did not lead to difference in survival to discharge – MedPage Today (necessário cadastro gratuito)
Comentário no Twitter
Among patients in pediatric ICUs, a bundled intervention that emphasized physiologically focused CPR training and structured clinical event debriefing did not significantly improve patient survival to hospital discharge with favorable neurologic outcome. https://t.co/MbmmSM0Xrt
— JAMA (@JAMA_current) March 8, 2022
Estudo randomizado | Em pacientes com parada cardíaca refratária fora do hospital, uma estratégia de transporte durante a ressuscitação, ressuscitação cardiopulmonar extracorpórea e estudo invasivo imediato não trouxe melhora significativa para a sobrevida com um desfecho neurológico favorável (OR 1,63; IC 95% 0,93 a 2,85; P = 0,09).
10 Mar, 2022 | 15:55hEffect of Intra-arrest Transport, Extracorporeal Cardiopulmonary Resuscitation, and Immediate Invasive Assessment and Treatment on Functional Neurologic Outcome in Refractory Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial – JAMA (link para o resumo – $ para o texto completo)
Comentário: Early Invasive Therapy for Out-of-Hospital Cardiac Arrest – American College of Cardiology
Comentário no Twitter
In this randomized clinical trial, early intra-arrest transport, extracorporeal CPR, and invasive assessment and treatment did not significantly improve survival with neurologically favorable outcome at 180 days compared with standard resuscitation. https://t.co/qSqWSFFpOF pic.twitter.com/SLu0bGHhq8
— JAMA (@JAMA_current) February 22, 2022


